Tetrodocain

From WikiProjectMed
Jump to navigation Jump to search

Tetrodocain (Korean: 테트로도카인주사약) is medical injection produced by the Korea Jangsaeng Joint Venture Company (조선장생합영회사) in North Korea. The injection was first claimed to be invented by the company in 2004.[1] According to the state-run Korean Central News Agency (KCNA), the main ingredient of the injection is tetrodotoxin, isolated from puffer poisons, and operates as an anaesthetic.[2] It has been sold for international export on sites based in Russia and China.[3]

KCNA described the medicine as efficacious in treating a wide range of diseases, including cancer, tuberculosis, chronic hepatitis, pancreatitis and HIV/AIDS.[4][5] These claims have been deemed to be either exaggerated or false.[3] The North Korean government also marketed its use in drug detoxification from narcotics such as opium, cocaine and heroin.[6]

Related works

North Korea released a supposed clinical research thesis about the usage of tetrodocain for anesthetics in 2015.[7]

See also

References

  1. ^ "북, 복어 독으로 차세대 진통제 개발". 2004-08-27.
  2. ^ "Natural Tetrodocain Injection". Korea News Service. Korean Central News Agency. 2 September 2009. Archived from the original on 6 September 2009. Retrieved 11 May 2021.
  3. ^ a b Fifield, Anna (10 August 2016). "We scrutinized North Korean 'Viagra' – and discovered it might actually work". The Washington Post. Retrieved 11 May 2021.
  4. ^ "Efficacious Tetrodocain Injection". Korea News Service. Korean Central News Agency. 26 August 2004. Archived from the original on 2 September 2004. Retrieved 11 May 2021.
  5. ^ "DPRK develops medicines with swellfish poison". People's Daily. Xinhua News Agency. 17 December 2010. Archived from the original on 12 May 2021. Retrieved 11 May 2021.
  6. ^ Hyun, Kwon Jeong (31 December 2005). "The Worst North Korean Export Goods in 2005". Daily NK. Retrieved 11 May 2021.
  7. ^ KIm Won-sik (2015-02-17). "(연구 및 성과)테트로도카인과 1%리도카인을 경막외병합주입하여 수술후 무통을 보장하기 위한 림상적연구". 의학과학출판사.